384 An investigation into the role of CD4+ tumor-infiltrating lymphocytes (TIL) in metastatic melanoma patients with a complete response to adoptive cell therapy
Main Authors: | Amy Hall, Shari Pilon-Thomas, John Mullinax, MacLean Hall, Allison Richards, Amod Sarnaik, Jamie Teer, Patrick Innamarato, Matthew Beatty, Jonathan Hensel, Holly Branthoover, Alex Alfaro, Jeani Rich, Jim Bender, Jake Ceccarelli, TJ Langer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer
by: Michael Poch, et al.
Published: (2018-09-01) -
The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications
by: Ahmet Murat Aydin, et al.
Published: (2021-02-01) -
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
by: Shari Pilon-Thomas, et al.
Published: (2023-10-01) -
346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers
by: Amy Hall, et al.
Published: (2023-11-01) -
195 Stimulation of tumor infiltrating B-cells improves ex-vivo TIL expansion for melanoma immunotherapy
by: Shari Pilon-Thomas, et al.
Published: (2021-11-01)